Li H, Sisoudiya SD, Martin-Giacalone BA, Khayat MM, Dugan-Perez S, Marquez-Do DA, Scheurer ME, Muzny D, Boerwinkle E, Gibbs RA, Chi Y, Barkauskas DA, Lo T, Hall D, Stewart DR, Schiffman JD, Skapek SX, Hawkins DS, Plon SE, Sabo A, Lupo PJ (2021) Germline Cancer Predisposition variants in Pediatric Rhabdomyosarcoma: a Report from the children’s Oncology Group. J Natl Cancer Inst 113:875–883. https://doi.org/10.1093/jnci/djaa204
Zhang J, Walsh MF, Wu G, Edmonson MN, Gruber TA, Easton J, Hedges D, Ma X, Zhou X, Yergeau DA, Wilkinson MR, Vadodaria B, Chen X, McGee RB, Hines-Dowell S, Nuccio R, Quinn E, Shurtleff SA, Rusch M, Patel A, Becksfort JB, Wang S, Weaver MS, Ding L, Mardis ER, Wilson RK, Gajjar A, Ellison DW, Pappo AS, Pui C, Nichols KE, Downing JR (2015) Germline mutations in predisposition genes in Pediatric Cancer. N Engl J Med 373:2336–2346. https://doi.org/10.1056/NEJMoa1508054
Article CAS PubMed PubMed Central Google Scholar
Parsons DW, Roy A, Yang Y, Wang T, Scollon S, Bergstrom K, Kerstein RA, Gutierrez S, Petersen AK, Bavle A, Lin FY, López-Terrada DH, Monzon FA, Hicks MJ, Eldin KW, Quintanilla NM, Adesina AM, Mohila CA, Whitehead W, Jea A, Vasudevan SA, Nuchtern JG, Ramamurthy U, McGuire AL, Hilsenbeck SG, Reid JG, Muzny DM, Wheeler DA, Berg SL, Chintagumpala MM, Eng CM, Gibbs RA, Plon SE (2016) Diagnostic Yield of Clinical Tumor and Germline Whole-Exome sequencing for children with solid tumors. JAMA Oncol 2:616–624. https://doi.org/10.1001/jamaoncol.2015.5699
Article PubMed PubMed Central Google Scholar
Rushlow D, Piovesan B, Zhang K, Prigoda-Lee NL, Marchong MN, Clark RD, Gallie BL (2009) Detection of mosaic RB1 mutations in families with retinoblastoma. 30:842–851. https://doi.org/10.1002/humu.20940
Skalet AH, Gombos DS, Gallie BL, Kim JW, Shields CL, Marr BP, Plon SE, Chévez-Barrios P (2018) Screening children at risk for Retinoblastoma: Consensus Report from the American Association of Ophthalmic. Oncologists Pathologists 125:453–458. https://doi.org/10.1016/j.ophtha.2017.09.001
Kahn RM, Ahsan MD, Chapman-Davis E, Holcomb K, Nitecki R, Rauh-Hain JA, Fowlkes RK, Tubito F, Pires M, Christos PJ, Tkachuk K, Krinsky H, Sharaf RN, Offit K, Lipkin S, Frey MK (2023) Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome? Fam Cancer 22:127–133. https://doi.org/10.1007/s10689-022-00316-x
Mody RJ, Wu Y, Lonigro RJ, Cao X, Roychowdhury S, Vats P, Frank KM, Prensner JR, Asangani I, Palanisamy N, Dillman JR, Rabah RM, Kunju LP, Everett J, Raymond VM, Ning Y, Su F, Wang R, Stoffel EM, Innis JW, Roberts JS, Robertson PL, Yanik G, Chamdin A, Connelly JA, Choi S, Harris AC, Kitko C, Rao RJ, Levine JE, Castle VP, Hutchinson RJ, Talpaz M, Robinson DR, Chinnaiyan AM (2015) Integrative clinical sequencing in the management of Refractory or Relapsed Cancer in Youth. JAMA 314:913–925. https://doi.org/10.1001/jama.2015.10080
Article CAS PubMed PubMed Central Google Scholar
Barnoy S, Dagan E, Kim S, Caiata-Zufferey M, Katapodi MC (2023) Privacy and utility of genetic testing in families with hereditary cancer syndromes living in three countries: the international cascade genetic screening experience. Front Genet 14:1109431. https://doi.org/10.3389/fgene.2023.1109431
Article PubMed PubMed Central Google Scholar
Knoll J, Li A, Smith CH, Schratz K, Cooper SL, Meah T, Helmke E, Pratilas CA, Bodurtha J (2021) Improving detection of Cancer Predisposition syndromes in Pediatric Oncology. J Pediatr Hematol Oncol 43:e891–e896. https://doi.org/10.1097/MPH.0000000000001987
Lee M, Lui ACY, Chan JCK, Doong PHL, Kwong AKY, Mak CCY, Li RHW, Kan ASY, Chung BHY (2023) Revealing parental mosaicism: the hidden answer to the recurrence of apparent de novo variants 17:91. https://doi.org/10.1186/s40246-023-00535-y
Campbell IM, Yuan B, Robberecht C, Pfundt R, Szafranski P, McEntagart ME, Nagamani SCS, Erez A, Bartnik M, Wisniowiecka-Kowalnik B, Plunkett KS, Pursley AN, Kang SL, Bi W, Lalani SR, Bacino CA, Vast M, Marks K, Patton M, Olofsson P, Patel A, Veltman JA, Cheung SW, Shaw CA, Vissers LELM, Vermeesch JR, Lupski JR, Stankiewicz P (2014) Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders. Am J Hum Genet 95:173–182. https://doi.org/10.1016/j.ajhg.2014.07.003
Article CAS PubMed PubMed Central Google Scholar
Sippel KC, Fraioli RE, Smith GD, Schalkoff ME, Sutherland J, Gallie BL, Dryja TP (1998) Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counseling. Am J Hum Genet 62:610–619. https://doi.org/10.1086/301766
Article CAS PubMed PubMed Central Google Scholar
Hansford JR, Das A, McGee RB, Nakano Y, Brzezinski J, Scollon SR, Rednam SP, Schienda J, Michaeli O, Kim SY, Greer MC, Weksberg R, Stewart DR, Foulkes WD, Tabori U, Pajtler KW, Pfister SM, Brodeur GM, Kamihara J (2024) Update on Cancer Predisposition syndromes and Surveillance guidelines for Childhood Brain tumors. Clin Cancer Res 30:2342–2350. https://doi.org/10.1158/1078-0432.CCR-23-4033
George R, Kovak K, Cox SL (2015) Aligning policy to Promote Cascade Genetic Screening for Prevention and Early Diagnosis of Heritable Diseases. J Genet Counsel 24:388–399. https://doi.org/10.1007/s10897-014-9805-5
Gigante L, Paganini I, Frontali M, Ciabattoni S, Sangiuolo FC, Papi L (2016) Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism. Fam Cancer 15:123–126. https://doi.org/10.1007/s10689-015-9836-6
Knight LM, Miller E, Kovach J, Arscott P, von Alvensleben JC, Bradley D, Valdes SO, Ware SM, Meyers L, Travers CD, Campbell RM, Etheridge SP (2020) Genetic testing and cascade screening in pediatric long QT syndrome and hypertrophic cardiomyopathy. 17:106–112. https://doi.org/10.1016/j.hrthm.2019.06.015
COMMITTEE ON GENETICS A, Fallat ME, Katz AL, Mercurio MR, Moon MR, Okun AL, Webb SA, Weise KL, Saul RA, Braddock SR, Chen E, Freedenberg DL, Jones MC, Perrin JM, Tarini BA, David KL, Bartoshesky LE, Anderson RR, Best RG, Hoffman JD, Ito M, Lemke AA, Murray ML, Sharp RR, Bhambhani V (2013) Ethical and Policy issues in genetic testing and screening of children. Pediatrics 131:620–622. https://doi.org/10.1542/peds.2012-3680
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf 42:377–381. https://doi.org/10.1016/j.jbi.2008.08.010
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN (2019) The REDCap consortium: building an international community of software platform partners. J Biomed Inf 95:103208. https://doi.org/10.1016/j.jbi.2019.103208
StataCorp SCL (2023) Stata Statistical Software: Release 18. Release 18
Williams S, Hill K, Mathew MS, Messiah SE (2024) Disparities in Patient Family Social Determinants of Health in a large urban Pediatric Health System. J Pediatr Health Care 38:172–183. https://doi.org/10.1016/j.pedhc.2023.11.005
Cochran ED, Jacobson JC, Nehrubabu M, Qiao J, McCreery S, Chung DH (2024) Social determinants of outcomes Disparity among Pediatric patients with solid tumor. J Am Coll Surg 238:463–478. https://doi.org/10.1097/XCS.0000000000001010
Chiang J, Chua Z, Chan JY, Sule AA, Loke WH, Lum E, Ong MEH, Graves N, Ngeow J (2024) Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review. NPJ Genom Med 9:26–20. https://doi.org/10.1038/s41525-024-00412-0
Article PubMed PubMed Central Google Scholar
Agiannitopoulos K, Potska K, Katseli A, Ntogka C, Tsaousis GN, Pepe G, Bouzarelou D, Tsoulos N, Papathanasiou A, Ziogas D, Venizelos V, Markopoulos C, Iosifidou R, Karageorgopoulou S, Giassas S, Natsiopoulos I, Papazisis K, Vasilaki-Antonatou M, Psyrri A, Koumarianou A, Matthaios D, Zairi E, Blidaru A, Banu E, Jinga DC, Laçin Ş, Özdoğan M, Papadopoulou E, Nasioulas G (2023) Only 32.3% of breast Cancer families with pathogenic variants in Cancer genes utilized Cascade Genetic Testing. Cancers (Basel) 15:5218. https://doi.org/10.3390/cancers15215218
Article CAS PubMed Google Scholar
Mendez M, Panganiban K, Kieran K (2024) Guess who’s coming to Clinic? Companions in a Pediatric Urology Clinic. J Surg Res 297:144–148. https://doi.org/10.1016/j.jss.2024.01.025
Lieberman S, Lahad A, Tomer A, Koka S, BenUziyahu M, Raz A, Levy-Lahad E (2018) Familial communication and cascade testing among relatives of BRCA population screening participants. 20 1446–1454. https://doi.org/10.1038/gim.2018.26
Cheung EL, Olson AD, Yu TM, Han PZ, Beattie MS (2010) Communication of BRCA results and family testing in 1,103 high-risk women. Cancer Epidemiol Biomarkers Prev 19:2211–2219. https://doi.org/10.1158/1055-9965.EPI-10-0325
Article CAS PubMed PubMed Central Google Scholar
Srinivasan S, Won Nae, Dotson D, Wright Sarah, Roberts M (2020) Barriers and facilitators for cascade testing in genetic conditions: a. Syst Rev 28:1631–1644. https://doi.org/10.1038/s41431-020-00725-5
Campbell M, Humanki J, Zierhut H (2017) A novel approach to screening for familial hypercholesterolemia in a large public venue. J Community Genet 8:35–44. https://doi.org/10.1007/s12687-016-0285-1
Campbell-Salome G, Jones LK, Walters NL, Morgan KM, Brangan A, Ladd IG, McGowan MP, Wilemon K, Schmidlen TJ, Simmons E, Schwartz MLB, McMinn MN, Tricou E, Rahm AK, Ahmed CD, Sturm AC (2023) Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia. BMC Health Serv Res 23:340–y. https://doi.org/10.1186/s12913-023-09304-y
留言 (0)